A Yakima County resident exposed to infected dairy cattle has died of avian influenza. A third human case has also been confirmed as H5N1 spreads to 33 herds in the county.
|Articles|September 3, 2020
Pursuit of Non-COVID Medical Care Linked to Mental Wellbeing
Author(s)Grant M. Gallagher
A review of the week's top infectious disease news, including links established between mental health and pursuit of need medical care during COVID-19.
Advertisement
Transcript:
Welcome to the Contagion News Network.
I’m assistant editor Grant Gallagher, here with the week’s top stories in infectious diseases.
A new study suggests connections between widespread mental health challenges and the decline in care during COVID-19.
While fear of the virus is also a factor, according to a recent study published by investigators in the
According to results drawn from a weekly survey, individuals who experience symptoms of anxiety and depression had higher relative risk for delayed medical care and not receiving necessary non-COVID medical care, after adjustment for potential confounders.
Emergency health care use has declined by 10% for hyperglycemic crises, 20% for strokes, and 23% for heart attacks.
Ambulatory visits have also declined by almost 60%.
In other news, a
Odds of better clinical status were higher for patients with moderate COVID-19 who received a 5-day course of remdesivir than for those receiving standard care, according to the most recent randomized clinical trial of the antiviral drug.
Now, on to an interview with speech pathologist Rinki Varindani Desai, who shares some of the challenges COVID-19 patients with lung injury have faced in recovery. Thanks for watching.
Advertisement
Related to this article
Voceryq earned FDA accelerated approval for adults with RRP after 7 of 26 patients (27%) needed no surgery for 12 months in RRP-001; a confirmatory trial is required.
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Investigational agent Zelicapavir cut time to complete RSV symptom resolution by up to a week and lowered hospitalization in high-risk adults.
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.
Oral zelicapavir cut time to complete RSV symptom resolution by up to 1 week in high-risk adults, but it did not meet its primary end point in a phase 2 trial.
Advertisement
Advertisement
Trending on Contagion Live
1
Nearly 30% of US Adults Report Misrepresenting Symptoms to Get Antibiotics
2
Fungal-WHAT? Updates to the WHO Antifungal Pipeline
3
From Pathogen to Infectious Disease Diagnosis: Reflex Testing Targets Hepatitis D Gap
4
FDA Tentatively Approves First Generic Lenacapavir PrEP for 120 LMICs
5